Revenue from Contract with Customer, Excluding Assessed Tax of Akari Therapeutics Plc from 31 Dec 2022 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Akari Therapeutics Plc quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2022 to 30 Jun 2024.
  • Akari Therapeutics Plc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Jun 2024 was $0.
  • Akari Therapeutics Plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $367,877, a 39% decline from 2022.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

Akari Therapeutics Plc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $0 $0 01 Apr 2024 30 Jun 2024 8-K 06 Sep 2024
Q2 2023 $0 01 Apr 2023 30 Jun 2023 8-K 06 Sep 2024

Akari Therapeutics Plc Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $367,877 -$239,804 -39% 01 Jan 2023 31 Dec 2023 8-K 06 Sep 2024
2022 $607,681 01 Jan 2022 31 Dec 2022 8-K 06 Sep 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.